Naimish Patel, Chief Medical Officer: Crispr Therapeutics CRSP Buy · Filed 01/27

Trade details

Type: Insider buy
Amount: $49,703.68
Shares · price: 1,508 sh · $32.96 a share
Held after: 1,508 sh
Stock: Crispr Therapeutics CRSP
Person: Naimish PatelChief Medical Officer
Trade date: 25/04/03
Filed: 26/01/27
Days to filing: 299 days

First buy since 2023

Insiders buying this week: 1 insiders

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/04~25/05/03

Naimish Patel's recent trades

Naimish PatelChief Medical Officer
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$210.6K
3,786 sh
$210.6K
Filed 06/01
Traded 05/29
Naimish PatelChief Medical Officer
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$152K
3,150 sh
$152K
Filed 03/17
Traded 03/16
Naimish PatelChief Medical Officer
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$141.3K
3,932 sh
$141.3K
Filed 25/05/30
Traded 25/05/29